This finding initiated decades of extensive immunochemical studies of immunoglobulin structure and function that eventually established that effective vaccination depends on the generation of an ...
IGM Biosciences ended last year laying off staff and streamlining its cancer pipeline. Now, the company has become the latest to join a hot trend in cell therapy biotech—pivoting from oncology ...
IGM Biosciences shifts focus to autoimmune disease research, cutting oncology spending and reducing its workforce. Leadership changes include the appointment of former Bristol Myers' executive ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
IGM Financial Inc. operates as a wealth and asset management company in Canada. It operates through Wealth Management and Asset Management segments. The Wealth Management segment offers ...
On Tuesday, IGM Biosciences Inc. (NASDAQ:IGMS) announced a strategic pivot and pipeline transformation to accelerate and deepen its leadership in developing T cell-engaging IgM antibodies for ...